A.I.R VACCINES
Dead / Abandoned — Abandoned — no statement of use filed (as of 24 Apr 2023)
What this means for you
This application is over — abandoned 24 Apr 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87866110
- Mark type
- Stylized text
- Filed
- 06 Apr 2018
- Published for opposition
- 28 Jan 2020
- Abandoned
- 24 Apr 2023
- Attorney of record
- Allison R. Imber
Goods and services
- Class 001 — Chemicals: Active chemical ingredients for use in manufacture of anti-cancer drugs and vaccines, namely, nucleic acids, amplifying nucleic acids, peptides, and proteins, all of the foregoing for laboratory use
- Class 005 — Pharmaceuticals: Human and veterinary pharmaceutical preparations comprising nucleic acids, amplifying nucleic acids, viruses, viral like particles, peptides and proteins, the foregoing being for use in the prevention and treatment of cancer, infectious diseases, and immunological diseases
Owner
- BioNTech SE, Mainz, DE
- BioNTech RNA Pharmaceuticals GmbH, Mainz, DE
- BioNTech RNA Pharmaceuticals GmbH, Mainz, DE
Prosecution history
- 24 Apr 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 24 Apr 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 29 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Sept 2022 — SOU EXTENSION 5 GRANTED
- 19 Sept 2022 — SOU EXTENSION 5 FILED
- 19 Sept 2022 — SOU TEAS EXTENSION RECEIVED
- 22 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Mar 2022 — SOU EXTENSION 4 GRANTED
- 18 Mar 2022 — SOU EXTENSION 4 FILED
- 18 Mar 2022 — SOU TEAS EXTENSION RECEIVED
- 14 Oct 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Oct 2021 — SOU EXTENSION 3 GRANTED
- 20 Sept 2021 — SOU EXTENSION 3 FILED
- 06 Oct 2021 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 22 Sept 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL